Literature DB >> 20393303

Gene patents and licensing: case studies prepared for the Secretary's Advisory Committee on Genetics, Health, and Society.

Robert Cook-Deegan1, Christopher Heaney.   

Abstract

Researchers at the Center for Public Genomics at Duke University analyzed how patenting and licensing affect clinical access to genetic testing in the United States. The research was requested by the Secretary's Advisory Committee on Genetics, Health, and Society. Conditions studied were breast and ovarian cancers, colon cancers, Alzheimer disease, cystic fibrosis, hearing loss, hereditary hemochromatosis, long QT syndrome, spinocerebellar ataxia, Tay-Sachs disease, and Canavan disease.

Entities:  

Mesh:

Year:  2010        PMID: 20393303      PMCID: PMC2917582          DOI: 10.1097/GIM.0b013e3181d694b0

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  2 in total

1.  Evidence and anecdotes: an analysis of human gene patenting controversies.

Authors:  Timothy Caulfield; Robert M Cook-Deegan; F Scott Kieff; John P Walsh
Journal:  Nat Biotechnol       Date:  2006-09       Impact factor: 54.908

2.  Patenting and licensing in genetic testing: recommendations of the European Society of Human Genetics.

Authors:  S Aymé; Gert Matthijs; S Soini
Journal:  Eur J Hum Genet       Date:  2008-05       Impact factor: 4.246

  2 in total
  6 in total

1.  New court ruling may alter the legal landscape for gene patents.

Authors:  Robert I Field
Journal:  P T       Date:  2010-06

2.  Cystic Fibrosis Patents: A Case Study of Successful Licensing.

Authors:  Mollie A Minear; Cristina Kapustij; Kaeleen Boden; Subhashini Chandrasekharan; Robert Cook-Deegan
Journal:  LES Nouv       Date:  2013-03-01

Review 3.  Commercial landscape of noninvasive prenatal testing in the United States.

Authors:  Ashwin Agarwal; Lauren C Sayres; Mildred K Cho; Robert Cook-Deegan; Subhashini Chandrasekharan
Journal:  Prenat Diagn       Date:  2013-06       Impact factor: 3.050

4.  Gene patents and personalized cancer care: impact of the Myriad case on clinical oncology.

Authors:  Kenneth Offit; Angela Bradbury; Courtney Storm; Jon F Merz; Kevin E Noonan; Rebecca Spence
Journal:  J Clin Oncol       Date:  2013-06-13       Impact factor: 44.544

5.  Access to personalized medicine: factors influencing the use and value of gene expression profiling in breast cancer treatment.

Authors:  Y Bombard; L Rozmovits; M Trudeau; N B Leighl; K Deal; D A Marshall
Journal:  Curr Oncol       Date:  2014-06       Impact factor: 3.677

Review 6.  After Myriad: Genetic Testing in the Wake of Recent Supreme Court Decisions about Gene Patents.

Authors:  Robert Cook-Deegan; Annie Niehaus
Journal:  Curr Genet Med Rep       Date:  2014
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.